Browse resources
Region: Global
Total results with these characteristics: 876
- The Communication Initiative Network
This site contains links to select programs, data, and materials, from various development organizations focused on immunization initiatives, including avian influenza and polio.
Author: The Communication Initiative Network
- Comparative Review of Three Cost-Effectiveness Models for Rotavirus Vaccines in National Immunization Programs: A Generic Approach Applied to Various Regions in the World
This article, published in BMC Medicine, critically reviews available cost-effectiveness models for rotavirus vaccination, comparing their designs using a standardized approach and studying the similarities and differences in cost-effectiveness …
Author: Postma MJ, Jit M, Rozenbaum MH, Standaert BA, Tu HA, Hutubessy RCW
Published: 2011
- The Compelling Need for Game-Changing Influenza Vaccines: An Analysis of the Influenza Vaccine Enterprise and Recommendations for the Future
This report provides a review of all aspects of influenza vaccine research and development, financing, manufacturing, efficacy, safety, regulatory issues, procurement, distribution, usage, public education, consumer acceptance, and public policy. …
Author: Center for Infectious Disease Research & Policy
Published: 2012
- A Comprehensive Approach to Rotavirus Vaccines
This fact sheet highlights PATH's work to address rotavirus and includes general information about its efforts to increase access to and effectiveness of existing vaccines, as well as to develop new vaccines.
Author: PATH
Published: 2011
- Comprehensive Cervical Cancer Prevention and Control: A Healthier Future for Girls and Women
This WHO Guidance Note advocates for a comprehensive approach to cervical cancer prevention and control and is aimed at senior policy makers and programme managers. It describes the need to deliver effective interventions across the female life …
Author: World Health Organization
Published: 2013
- Conducting Formative Research for HPV Vaccination Program Planning: Practical Experience from PATH
From 2006 to 2011, PATH conducted demonstration projects in four low- and middle-income countries—India, Peru, Uganda, and Vietnam—to provide evidence for decision-making about public-sector introduction of human papillomavirus (HPV) …
Author: PATH
Published: 2012
- Conjugate Vaccines
This review, published in Expert Review of Vaccines, looks at what has been learned from developing conjugate vaccines against Haemophilus influenzae type b, Streptococcus pneumoniae, and group C Neisseria meningitidis that could be useful for the …
Author: Lockhart S
Published: 2003
- Conjugate Vaccines and the Carriage of Haemophilus influenzae type b
Many junior doctors today have not had occasion to treat a child for Hib disease. The remarkable absence of cases of this disease is due to the use of conjugate vaccines. In countries with established Hib vaccination programs the incidence of …
Author: Barbour M
Published: 1996
- The Contribution of Specific Pneumococcal Serogroups to Different Disease Manifestations: Implications for Conjugate Vaccine Formulation and Use, Part II
To assess whether certain serogroups of Streptococcus pneumoniae are preferentially associated with specific disease manifestations, we analyzed all recent pneumococcal disease studies and assessed the relative frequency of isolation of each …
Author: Hausdorff WP, Bryant J, Paradiso P, Siber G
Published: 2000
- Control of Epidemic Meningococcal Disease. WHO Practical Guidelines. 2nd Edition
These guidelines, designed for physicians, laboratory workers, and health care administrators, provide comprehensive information on epidemiology and standard techniques for diagnosis, treatment, prevention, and control of meningococcal disease …
Author: World Health Organization
Published: 1998
- Control of Japanese Encephalitis--Within Our Grasp?
The article, from the New England Journal of Medicine, provides an up-to-date summary of JE disease incidence, epidemiology, and vaccines against JE.
Author: Solomon T
Published: 2006
- Coordinated Surveillance and Detection of Pneumococcal and Haemophilus influenzae type b (Hib) Disease in Developing Countries
This supplemental issue of Clinical Infectious Diseases provides numerous articles on the surveillance and detection of pneumococcal and Haemophilus influenzae type b disease in developing countries. Topics include progress and challenges in disease …
Author: Black S, Knoll MD, eds.
Published: 2009
- The Cornerstone of Public Health
This fact sheet makes the case for why vaccines are a critical, cost-effective investment for improving global health and saving children's lives.
Author: PATH
Published: 2012
- Correlates of Protection: Novel Generations of Influenza Vaccines
This article, published in the journal Vaccine, reviews potential correlates of protection against influenza and discusses some of the vaccination strategies that could result in optimal protection against epidemic and pandemic influenza. ABSTRACT …
Author: Rimmelzwaan GF, McElhaney JE
Published: 2008
- Cost Effectiveness of Rotavirus Vaccines and Other Interventions for Diarrhoeal Diseases: Meeting Report 2006
This report from the WHO's Weekly Epidemiologic Record summarizes a meeting convened by PATH, WHO, and the US Centers for Disease Control and Prevention (CDC) on the economic burden of rotavirus disease and cost-effectiveness of vaccines. The …
Author: World Health Organization
Published: 2006
- The Cost of Immunization Programs in the Next 10 Years
This paper summarizes the results of a WHO/UNICEF study on the potential impact of immunization over the next decade and the financing required for immunization activities in the 72 poorest countries of the world.
Author: World Health Organization
Published: 2006
- Cost-Effectiveness and Economic Benefits of Vaccines in Low- and Middle-Income Countries: A Systematic Review
This review, published in Vaccine, documents the available evidence showing that vaccination in low- and middle-income countries brings important economic benefits. The cost-effectiveness studies reviewed suggest to policy makers that vaccines are …
Author: Ozawa S, Mirelman A, Stack ML, Walker DG, Levine OS
Published: 2012
- Cotton Rats Previously Immunized With a Chimeric RSV FG Glycoprotein Develop Enhanced Pulmonary Pathology When Infected With RSV, a Phenomenon not Encountered Following Immunization With Vaccinia-RSV Recombinants or RSV
In studies conducted in the 1960s, children previously immunized with a formalin-inactivated respiratory syncytial virus (RSV) vaccine (FI-RSV) developed a greater incidence and severity of pulmonary disease during subsequent natural RSV infection …
Author: Connors M, Collins PL, Firestone CY, et al.
Published: 1992
- The Cure That Kills
This paper examines the health risks posed by unsafe injections in Africa and outlines some of the programs that are helping reduce these risks.
Author: Practical Patient Care
Published: 2008
- Current HPV Vaccines and Future AIDS Vaccines: Common Challenges and Unprecedented Opportunities
This issue brief discusses how ensuring swift and efficient HPV vaccine introduction in developing countries will not only help address the burden of cervical cancer, but will also provide a valuable opportunity for AIDS vaccine researchers and …
Author: AIDS Vaccine Advocacy Coalition, International AIDS Vaccine Initiative, PATH
Published: 2008
- Current Knowledge Regarding the Investigational 13-valent Pneumococcal Conjugate Vaccine
This article, published in Expert Reviews of Vaccines, explains the latest knowledge about the investigational 13-valent pneumococcal conjugate vaccine (PCV-13). It outlines the composition of the vaccine and the trials it has undergone to date …
Author: Dinleyici EC, Yargic ZA
Published: 2009
- Current Use and Development of Vaccines for Japanese Encephalitis
This literature review, published in Expert Opinion on Biological Therapy, analyzes use of current JE vaccines and development of alternative vaccine candidates.
Author: Beasley D, Lewthwaite P, Solomon T.
Published: 2008
- Decade of Vaccines Collaboration
This website provides information about the DoV Collaboration which was launched in 2010 to enhance coordination across the global community by bringing together diverse stakeholders to develop an evidence-based, country-led global vaccine action …
Author: Decade of Vaccines (DoV) Collaboration
- Decline in Invasive Pneumococcal Disease After the Introduction of Protein-Polysaccharide Conjugate Vaccine
Published in the New England Journal of Medicine, this study examined population-based data from the Active Bacterial Core Surveillance of the Centers for Disease Control and Prevention to evaluate changes in the burden of invasive disease, defined …
Author: Whitney C, Farley M, Hadler J, et al.
Published: 2003
- Decline in Pneumonia Admissions After Routine Childhood Immunization with Pneumococcal Conjugate Vaccine in the USA: A Time-Series Analysis
Published in The Lancet, this article assesses the effect of routine infant immunization with seven-valent pneumococcal conjugate vaccine (PCV7) on rates of all-cause and pneumococcal pneumonia admissions. ABSTRACT ONLY. (Learn how users in …
Author: Grijalva CG, Nuorti JP, Arbogast PG, et al.
Published: 2007

